Telehealth-Based Chronic Disease Management for Type 2 Diabetes

Launched by ZENG LIN, PH. D. · Dec 2, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help manage type 2 diabetes using a combination of online and in-person care. Researchers want to see how this approach affects patients' health, how much it costs, and which patients might benefit the most. They will include 1,636 participants who are between 18 and 70 years old and have been diagnosed with type 2 diabetes, but have not been able to meet their blood sugar and blood pressure goals. Participants need to be comfortable using smartphones to join online sessions and have someone who can assist them in keeping track of their blood sugar levels.

If you decide to participate, you will be followed for six months after you join the study. The researchers will collect information about your health before you start and will provide follow-up care based on your needs and the doctor's recommendations. It’s important to know that some people may not be able to join the study, especially those with severe complications from diabetes or other serious health issues. Overall, this trial aims to create a toolkit that can help people better manage their chronic conditions like diabetes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18-70 years old;
• • Confirmed diagnosis of type 2 diabetes mellitus;
• • Ability to use smartphones to participate in online diagnosis and treatment;
• • Ability of the patient or relatives to assist the patient in self-monitoring of blood glucose;
• • Failure to meet control targets: glycated hemoglobin ≥7. 0%, or LDL-C ≥ 2.6 mmol/L (and ASCVD or definite atherosclerosis with stenosis ≥ 1.8 mmol/L), or blood pressure \> 130% and ≥ 1.8 mmol/kg. L), or blood pressure over 130/80 mmHg.
• Exclusion Criteria:
• • Mental illness, cognitive dysfunction;
• • Other diseases and complex conditions (untreated tumors, heart disease within 3 months);
• • Acute complications of diabetes, severe hyperglycemia, fasting glucose greater than 16.9 mmol / L, random glucose greater than 20 mmol / L. Diabetic ketoacidosis and hypoglycemic coma that are not suitable for online management of diabetes emergencies;
• • Patients with severe chronic complications of diabetes in critical condition (blindness, vision deterioration, new onset of ASCVD symptoms);
• • Those who are unsuitable for the study: infection, fracture, trauma, foot ulceration, edema, blindness, cardiovascular emergencies, coma, etc;
• • Those who have not signed the informed consent form.